MYC and Mobius syndrome: By integrating the transcriptomic and genomic profiles from our newly diagnosed and publicly available MB cohorts3,4,22,24, we found that CTDNEP1 mutations, which present predominantly in MYC-driven MBs, define a specific subset of aggressive MB tumors.